New diabetes clinical trial: Semaglutide and Physical Activity for Obesity and Multimorbidity

Published on: January 30, 2024 at 11:00PM
Conditions: Obesity Morbid; Multimorbidity; Obesity
Interventions: Combination Product: Semaglutide 2.4 mg, total diet replacement, behavioural intervention
Sponsors: Hvidovre University Hospital
Not yet recruiting
https://ift.tt/EUOf92C